LU501835B1 - A standard method for inactivation of tumor biological activity program - Google Patents

A standard method for inactivation of tumor biological activity program

Info

Publication number
LU501835B1
LU501835B1 LU501835A LU501835A LU501835B1 LU 501835 B1 LU501835 B1 LU 501835B1 LU 501835 A LU501835 A LU 501835A LU 501835 A LU501835 A LU 501835A LU 501835 B1 LU501835 B1 LU 501835B1
Authority
LU
Luxembourg
Prior art keywords
tumor
stage
inactivation
treatment
program
Prior art date
Application number
LU501835A
Inventor
Pengfei Luo
Jiancheng Li
Jian Wang
Yixuan Li
Original Assignee
Shanghai Hongpeng New Tumor Tech Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Hongpeng New Tumor Tech Center filed Critical Shanghai Hongpeng New Tumor Tech Center
Priority to LU501835A priority Critical patent/LU501835B1/en
Application granted granted Critical
Publication of LU501835B1 publication Critical patent/LU501835B1/en
Priority to PCT/CN2022/132452 priority patent/WO2023197602A1/en

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/40—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/90—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to alternative medicines, e.g. homeopathy or oriental medicines
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H30/00—ICT specially adapted for the handling or processing of medical images
    • G16H30/40—ICT specially adapted for the handling or processing of medical images for processing medical images, e.g. editing

Abstract

This invention provides a standard method for inactivation of tumor biological activity program comprises the following steps: S1, tumor screening stage; S2, tumor control stage; S3, tumor shrinking stage; S4, tumor-killing stage; S5, tumor blocking stage. According to the invention, the scientific development concept is used to realize personalized analysis of tumor patients who are suitable for comprehensive treatment of tumor intervention, form a high-efficiency and low-toxicity tumor treatment scheme, apply the' program' logic, which makes the minimally invasive treatment of tumor strictly meaningful by adopting the corresponding characteristic technology for each specific stages; moreover, the new technology keeps pace with the times and is applied to the corresponding stage; the tumor diseases of patients can be diagnosed and treated more scientifically, efficiently and with low toxicity by strictly executing the program inactivation tumor activity scheme, so that the tumor treatment can be performed in minimally invasive intervention.
LU501835A 2022-04-13 2022-04-13 A standard method for inactivation of tumor biological activity program LU501835B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
LU501835A LU501835B1 (en) 2022-04-13 2022-04-13 A standard method for inactivation of tumor biological activity program
PCT/CN2022/132452 WO2023197602A1 (en) 2022-04-13 2022-11-17 A standard method for inactivation of tumor biological activity program

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU501835A LU501835B1 (en) 2022-04-13 2022-04-13 A standard method for inactivation of tumor biological activity program

Publications (1)

Publication Number Publication Date
LU501835B1 true LU501835B1 (en) 2022-10-13

Family

ID=83658177

Family Applications (1)

Application Number Title Priority Date Filing Date
LU501835A LU501835B1 (en) 2022-04-13 2022-04-13 A standard method for inactivation of tumor biological activity program

Country Status (2)

Country Link
LU (1) LU501835B1 (en)
WO (1) WO2023197602A1 (en)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6048686A (en) * 1998-05-05 2000-04-11 Randy Kyle Brown Hyperthermia and immunotherapy for cancer
US6725095B2 (en) * 2000-04-13 2004-04-20 Celsion Corporation Thermotherapy method for treatment and prevention of cancer in male and female patients and cosmetic ablation of tissue
WO2010082813A1 (en) * 2009-01-13 2010-07-22 Academisch Medisch Centrum Bij De Universiteit Van Amsterdam Method of treating cancer
CN109833473A (en) * 2017-11-24 2019-06-04 杨涛 A kind of tumor vaccine therapy method
CN108893443A (en) * 2018-07-24 2018-11-27 陕西九州细胞基因工程有限公司 A kind of Efficient amplification method of cytokine induction umbilical cord blood natural killer
CN110731821B (en) * 2019-09-30 2021-06-01 艾瑞迈迪医疗科技（北京）有限公司 Method and guide bracket for minimally invasive tumor ablation based on CT/MRI
CN113616410A (en) * 2020-05-06 2021-11-09 韩俊霞 Noninvasive targeting therapeutic mirror for human body natural channel tumor and control method thereof

Also Published As

Publication number Publication date
WO2023197602A1 (en) 2023-10-19

Similar Documents

Publication Publication Date Title
Safiyari-Hafizi et al. The health benefits of a 12-week home-based interval training cardiac rehabilitation program in patients with heart failure
ATE355852T1 (en) USE OF BOTULINUM TOXIN FOR THE TREATMENT OF HEART AND Circulatory Diseases
Ochi et al. Effects of anodal and cathodal transcranial direct current stimulation combined with robotic therapy on severely affected arms in chronic stroke patients.
de Paz et al. Combining transcranial direct-current stimulation with gait training in patients with neurological disorders: a systematic review
Zhuo et al. Repetitive transcranial magnetic stimulation as an adjunctive treatment for negative symptoms and cognitive impairment in patients with schizophrenia: a randomized, double-blind, sham-controlled trial
Schiena et al. Transcranial magnetic stimulation in major depressive disorder: Response modulation and state dependency.
Lehner et al. Efficacy and safety of repeated courses of rTMS treatment in patients with chronic subjective tinnitus
LU501835B1 (en) A standard method for inactivation of tumor biological activity program
ATE531813T1 (en) SYSTEM FOR MONITORING BACTERIAL TUMOR TREATMENT
Simis et al. Transcranial direct current stimulation combined with robotic training in incomplete spinal cord injury: a randomized, sham-controlled clinical trial
Shu et al. Neural modulation by repetitive transcranial magnetic stimulation (rTMS) for BCI enhancement in stroke patients
Marcori et al. Motor repertoire and gray matter plasticity: Is there a link?
Oh An integrative review of oncology nursing research in Korea: 1998-2003
Marzetti EEG brain networks identified by Hidden Markov model and their relation to TMS-evoked MEP amplitudes
Krasnoff Effects of auditory binaural beats on consciousness and the human nervous system: A transdisciplinary review of the evidence
Chiang et al. Modulation of the superior medial frontal cortex using anodal high definition transcranial direct current stimulation affects frontal midline theta oscillations during a Go-Nogo task in veterans with chronic traumatic brain injury
ATE503510T1 (en) HEART DISEASE TREATMENT SYSTEM
Nissim et al. Efficacy of Transcranial Alternating Current Stimulation (tACS) in the Enhancement of Working Memory Performance in Healthy Adults: an Exploratory Meta-Analysis
Hacker et al. P044 The effect of transcutaneous vagal nerve stimulation on experimental heat pain–A crossover blinded sham-and placebo-controlled investigation
DE60333476D1 (en) COMPOSITIONS FOR TREATING OR PREVENTING ANGIOGENESIS-DEPENDENT SYMPTOMS
Ilkhani et al. Effectiveness of the Westmead therapeutic method on preschool children with stuttering
Callahan et al. Associations Among Mental Health Care-seeking, Stigma, And Psychotherapy Readiness In Those With A Concussion History: 2604
rui Wu et al. Effect Of Flexi-bar Exercise Intervention On Cognitive Function Of Middle-aged And Elderly Women: 2605
Nguemeni et al. P 36 Split-belt training but not cerebellar anodal tDCS improves stability control and reduces risk of fall in patients with Multiple Sclerosis
Liang et al. Repetitive transcranial magnetic stimulation regulate brain networks effective connectivity patterns in the spectrum of preclinical Alzheimer's disease

Legal Events

Date Code Title Description
FG Patent granted

Effective date: 20221013